3-Methyl-4-(trifluoromethyl)-sydnone
![]() |
- $370 - $1086
- Product name: 3-Methyl-4-(trifluoromethyl)-sydnone
- CAS: 1067233-79-7
- MF: C4H3F3N2O2
- MW: 168.08
- EINECS:
- MDL Number:MFCD25948961
- Synonyms:3-Methyl-4-(trifluoromethyl)-sydnone
4 prices
Selected condition:
Brand
- AK Scientific
- Apolloscientific
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number8328AC
- Product description3-Methyl-4-(trifluoromethyl)-sydnone
- Packaging500mg
- Price$1086
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberPC200096
- Product description3-Methyl-4-(trifluoromethyl)-sydnone
- Packaging500mg
- Price$370
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11357172
- Product description3-Methyl-4-(trifluoromethyl)-1,2,3-oxadiazol-3-ium-5-olate 95+%
- Packaging1g
- Price$906
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101491
- Product description3-Methyl-4-(trifluoromethyl)-sydnone >90%
- Packaging500mg
- Price$768
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8328AC | 3-Methyl-4-(trifluoromethyl)-sydnone | 500mg | $1086 | 2021-12-16 | Buy |
Apolloscientific | PC200096 | 3-Methyl-4-(trifluoromethyl)-sydnone | 500mg | $370 | 2021-12-16 | Buy |
Crysdot | CD11357172 | 3-Methyl-4-(trifluoromethyl)-1,2,3-oxadiazol-3-ium-5-olate 95+% | 1g | $906 | 2021-12-16 | Buy |
Matrix Scientific | 101491 | 3-Methyl-4-(trifluoromethyl)-sydnone >90% | 500mg | $768 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|